CYP2C8 Exists as a Dimer in Natural Membranes

CYP2C8 with a modified N-terminal sequence (2C8H) crystallizes as a dimer, but it is not known whether native CYP2C8 exists as a dimer in natural membranes. We have examined the organization of 2C8H and CYP2C8 expressed in bacterial membranes and mammalian endoplasmic reticulum membranes, respectively, by cysteine scanning and cross-linking or oxidation of sulfhydryl groups. In both forms of CYP2C8, cross-linked dimers were observed that were eliminated by mutation of Cys-24 in the linker region. Introduction of individual cysteines in the N-terminal 21-amino acid membrane-spanning signal anchor resulted in a pattern of cross-linking consistent with an α-helical structure for the signal anchor. In the linker region, cross-linking was observed for cysteine substituted at residues 22, 23, or 24, just before three Arg residues, indicating close apposition of the two linker sequences despite the neighboring positive charges. Introduction into the F-G loop region of cysteine pairs optimally located for cross-linking based on the crystal structure resulted in cross-linked dimers in the Cys-24 mutant. Deletion of the signal anchor sequence eliminated cross-linking mediated by Cys-24 or by cysteines introduced in the F-G loop regions, indicating that the signal anchor interaction is required for stable dimer formation. These results indicate that the signal anchor sequence and the F-G loop region form interfaces for CYP2C8 intermolecular interactions in natural membranes.

[1]  D. Kirsch,et al.  Mapping Protein-Protein Interactions between MutL and MutH by Cross-linking* , 2004, Journal of Biological Chemistry.

[2]  M. J. Coon,et al.  On the mechanism of action of cytochrome P-450. Oxidation and reduction of the ferrous dioxygen complex of liver microsomal cytochrome P-450 by cytochrome b5. , 1984, The Journal of biological chemistry.

[3]  G. L. Hazelbauer,et al.  Deducing the organization of a transmembrane domain by disulfide cross-linking. The bacterial chemoreceptor Trg. , 1994, The Journal of biological chemistry.

[4]  G. L. Hazelbauer,et al.  Identification of functionally important helical faces in transmembrane segments by scanning mutagenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Sligar,et al.  Kinetics of dithionite-dependent reduction of cytochrome P450 3A4: heterogeneity of the enzyme caused by its oligomerization. , 2005, Biochemistry.

[6]  N. Harada,et al.  Core glycosylation of cytochrome P-450(arom). Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen. , 1993, The Journal of biological chemistry.

[7]  C David Stout,et al.  Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.

[8]  Eric F. Johnson,et al.  Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.

[9]  W. Pangborn,et al.  X-ray structure of human aromatase reveals an androgen-specific active site , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  Eric F. Johnson,et al.  Structures of Eukaryotic Cytochrome P450 Enzymes , 1995 .

[11]  M. Hwang,et al.  Oligomerization Is Crucial for the Stability and Function of Heme Oxygenase-1 in the Endoplasmic Reticulum* , 2009, The Journal of Biological Chemistry.

[12]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[13]  E. Hazai,et al.  INTERACTIONS BETWEEN CYP2C9 AND CYP2C19 IN RECONSTITUTED BINARY SYSTEMS INFLUENCE THEIR CATALYTIC ACTIVITY: POSSIBLE RATIONALE FOR THE INABILITY OF CYP2C19 TO CATALYZE METHOXYCHLOR DEMETHYLATION IN HUMAN LIVER MICROSOMES , 2005, Drug Metabolism and Disposition.

[14]  K. Mihara,et al.  A short amino‐terminal segment of microsomal cytochrome P‐450 functions both as an insertion signal and as a stop‐transfer sequence. , 1987, The EMBO journal.

[15]  T. Tracy,et al.  CYP2D6-CYP2C9 Protein-Protein Interactions and Isoform-Selective Effects on Substrate Binding and Catalysis , 2009, Drug Metabolism and Disposition.

[16]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[17]  Rebecca C Wade,et al.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? , 2005, EMBO reports.

[18]  S. Kawato,et al.  Rotation and membrane topology of genetically expressed methylcholanthrene-inducible cytochrome P-450IA1 lacking the N-terminal hydrophobic segment in yeast microsomes. , 1994, The Journal of biological chemistry.

[19]  E. Szczesna-Skorupa,et al.  Fluorescence Resonance Energy Transfer Analysis of Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells* , 2003, Journal of Biological Chemistry.

[20]  T. Tracy,et al.  CYP2C9-CYP3A4 Protein-Protein Interactions: Role of the Hydrophobic N Terminus , 2010, Drug Metabolism and Disposition.

[21]  S. Zhang,et al.  Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[22]  Eric F. Johnson,et al.  Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.

[23]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[24]  E. Szczesna-Skorupa,et al.  An N-terminal glycosylation signal on cytochrome P450 is restricted to the endoplasmic reticulum in a luminal orientation. , 1993, The Journal of biological chemistry.

[25]  T. Richardson,et al.  Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus. , 1997, Archives of biochemistry and biophysics.

[26]  Eric F. Johnson,et al.  Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric Enzyme , 2000, The Journal of Biological Chemistry.

[27]  D E McRee,et al.  Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. , 2000, Journal of inorganic biochemistry.

[28]  H. Barnes,et al.  Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Kawato,et al.  Dynamic structures of adrenocortical cytochrome P-450 in proteoliposomes and microsomes: protein rotation study. , 1992, Biochemistry.

[30]  M. J. Coon,et al.  Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region. , 1982, The Journal of biological chemistry.

[31]  T. Richardson,et al.  A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. , 1995, Archives of biochemistry and biophysics.

[32]  E. Szczesna-Skorupa,et al.  Identification of membrane-contacting loops of the catalytic domain of cytochrome P450 2C2 by tryptophan fluorescence scanning. , 2006, Biochemistry.

[33]  J. Casey,et al.  Cysteine-directed cross-linking localizes regions of the human erythrocyte anion-exchange protein (AE1) relative to the dimeric interface. , 2001, The Biochemical journal.

[34]  S. Sligar,et al.  Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium. , 2010, Biochimica et biophysica acta.

[35]  E. Szczesna-Skorupa,et al.  BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS , 2005, Drug Metabolism and Disposition.